Use of the content on this website
Unless otherwise indicated, the copyright in the information posted on this website (https://www.pmda.go.jp/) and its subdomain websites (hereinafter, the “Content”) is owned by the Pharmaceuticals and Medical Devices Agency (PMDA).
The Public Data License (Version 1.0) (PDL 1.0) (website of the Digital Agency) applies to the Content unless otherwise indicated.
For site-specific variations under PDL 1.0 (such as source citation examples specific to this website and the Content to which this license does not apply), see “Important Notes on the Public Data License (Version 1.0)” below.
Important Notes on the Public Data License (Version 1.0)
1.1 Source Citation
The user must cite the source when using the Content.
Please refer to the examples below and replace them as appropriate with the actual source name, URL, etc.
If URL links can be used, the URL shown in parentheses may be provided as a hyperlink to the relevant text.
- Source: Pharmaceuticals and Medical Devices Agency (PMDA) website (relevant page URL)
- Source: “XX Trend Survey” (Pharmaceuticals and Medical Devices Agency, PMDA) (relevant page URL)
If you edit the Content, you must include a statement indicating that it has been edited, in addition to the above-mentioned source citation. You must not publish disclose, or use the edited Content in a manner that could be misconstrued as having been created by a public institution.
(Example of source citation when you edit the Content for use)
- Created by editing the XX Trend Survey (Pharmaceuticals and Medical Devices Agency, PMDA) (relevant page URL)
- Created by Company YY based on the XX Trend Survey (Pharmaceuticals and Medical Devices Agency, PMDA) (relevant page URL)
1.4 Content to which these Site Policy do not apply
The following Content is not covered by these Site Policy.
- Official emblems, logos, and mascot character designs that represent the organization or its specific programs or initiatives.
(For details regarding the use of the PMDA logo, please contact the PR Section, Office of Planning and Operations, PMDA) - The Content where other terms of use apply with specific and rational reason.
Links
As a general rule, you do not need to obtain permission to link to pages on this website.
However, please follow any restrictions indicated on this website.
No notification is required prior to creating a link.
You must clearly indicate on your webpages that link points to the PMDA website.
URLs on this website, may change without prior notice.
If linked content is moved, please promptly update the link or take other appropriate action.
When linking to the PMDA website, you may use the designated link banners shown below.
However, these images may not be used for purposes other than linking to the PMDA website.
PMDA Website
Link: https://www.pmda.go.jp/
Banner Image 1
Banner Image 2
PMDA “Okusuri” Search
Link: https://www.pmda.go.jp/okusuri_search/
Banner Image 1
Banner Image 2
Viewing PDF Files
To view PDF files, the Adobe Reader application is required.
You can download it free of charge from the Adobe website.
For issues related to displaying PDF files or Adobe Reader, please refer to Adobe’s support database.
Notes on Downloading Information
When downloading information posted on this website, please note the following points;
- Please limit downloads to the minimum necessary.
- Bulk, excessive, or frequent downloads that place excessive load on the server are strictly prohibited.
Automated crawling or download applications are also not permitted. If excessive load caused by such activities is detected, access from specific connections may be restricted.
Contact Information
PR Section, Office of Planning and Operations, Pharmaceuticals and Medical Devices Agency (PMDA)
(except where other contact information is provided on subdomain websites)
Email: kouhou[at]pmda.go.jp
(Please replace [at] with “@” when sending emails.)
When reporting system issues, please provide as much detail as possible, including screen captures of the issue and your PC environment settings, to assist investigation.
The PMDA may contact you for additional information during the investigation process.
We’d appreciate your cooperation.